Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 5Sarcoma 3Lymphoid 3Tumor-Agnostic 2Plasma cell 2Other hematologic neoplasm 2Gynecologic 2Gastrointestinal 2Myeloid 1

Conditions

Rectal Neoplasms 1Pancreatic Neoplasms 1Lipodystrophy, Congenital Generalized 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 329Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 258lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Tetanus Toxoid × Gastrointestinal × Clear all
NCT03848182 2024-04-18

Analyzing Childhood Recall Antigens in Patients With Pancreatic Cancer

Albert Einstein College of Medicine

Phase 2 Terminated
10 enrolled 7 charts
Gastrointestinal

Pancreatic Neoplasms, Lipodystrophy, Congenital Generalized

NCT00027833 2014-01-06

Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡